Ignite Creation Date:
2024-05-06 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05263570
Status:
RECRUITING
Last Update Posted:
2022-09-13
First Post:
2022-01-17
Brief Title:
The Efficiency for Stage II-III HRHER2 Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World
Sponsor:
Shengjing Hospital
Organization:
Shengjing Hospital
Organization Data
Organization:
Shengjing Hospital
Class:
OTHER
Study ID:
HR-HER2-RWS-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shengjing Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Caigang Liu
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shengjing Hospital
Old Name:
None
Old Organization:
None